Barclays
AGIO icon

Barclays’s Agios Pharmaceuticals AGIO Stock Holding History

Barclays’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-30,000
Closed -$877K – 4830
2024
Q1 		$877K Sell
30,000
-30,000
-50% -$803K ﹤0.01% 3223
2023
Q4 		$1.34M Buy
+60,000
New +$1.34M ﹤0.01% 3227
2018
Q3 		– Sell
-27,000
Closed -$2.27M – 7086
2018
Q2 		$2.27M Hold
27,000
– – ﹤0.01% 2466
2018
Q1 		$2.21M Buy
+27,000
New +$2.09M ﹤0.01% 2367
2016
Q4 		– Sell
-358,400
Closed -$18.9M – 6577
2016
Q3 		$18.9M Buy
+358,400
New +$15.6M 0.02% 573

Other funds holding AGIO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

Barclays's AGIO Position: Q2 2026 in Review

Barclays reduced its Agios Pharmaceuticals (AGIO) stake by 7.9% in Q2 2026, selling an estimated $126K and leaving 48,300 shares worth $1.79M. The position accounts for ﹤0.01% of the portfolio, ranked #2410.

Barclays first reported a position in AGIO in Q3 2013 and has held it in 52 quarters since. The position peaked at $8.72M in Q4 2025. 238 funds tracked by Wall St. Rank hold AGIO as of Q2 2026.

  • Barclays held 48,300 shares of Agios Pharmaceuticals worth $1.79M as of Q2 2026.
  • Barclays sold 4,138 Agios Pharmaceuticals shares in Q2 2026, an estimated $126K.
  • Agios Pharmaceuticals made up ﹤0.01% of Barclays's portfolio in Q2 2026, its #2410 holding.
  • Barclays first reported a position in Agios Pharmaceuticals in Q3 2013 and has held it in 52 quarters since.
  • Barclays's Agios Pharmaceuticals position peaked at $8.72M in Q4 2025.
  • 238 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q2 2026.

Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.